Primary Peritoneal Carcinoma Clinical Trials

149 clinical trials for Primary Peritoneal Carcinoma across international registries, including 18 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• Data Collection for Patients With Low Grade Ovarian or Peritoneal Tumors — RECRUITING
• IGFBP-2 Vaccine to Prevent Ovarian Cancer Progression in Patients With Serologic Detection of Recurrence — RECRUITING · PHASE2
• Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal Cancer — RECRUITING · PHASE3
• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001) — RECRUITING · PHASE1
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas — RECRUITING · PHASE2
• A Phase II Randomized, Open Label Non-inferiority Study of NiraParib Maintenance After 3 vs. 6 Cycles of Platinum-based Chemotherapy in completeLy debUlked Advanced HRDpositive High-grade Ovarian Cancer patientS in First Line Therapy — RECRUITING · PHASE2
• A Study Comparing Perioperative Stress Reduction vs. Standard of Care in Ovarian Cancer (PRESERVE) — RECRUITING · NA
• Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 — RECRUITING · PHASE1
• Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF — RECRUITING · PHASE1
• Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) — RECRUITING · PHASE1
• A Study to Learn if 27T51, a Mucin-16 (MUC16) Protein Targeting Immune Cell Therapy, Administered Alone or in Combination is Safe and How Well it Works for Adult Participants With Recurrent or Treatment Resistant Ovarian Cancers — RECRUITING · PHASE1
• Survival Effect of Hepato-celiac Lymphadenectomy In Primary or Relapsed Ovarian Cancer — RECRUITING · NA
• Cryocompression With or Without Cilostazol for the Prevention of Paclitaxel-induced Neuropathy in Patients With Gynecological Cancers — RECRUITING · PHASE2
• Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer — RECRUITING · PHASE2
• Surgery Combined With Maintenance Targeted Therapy in the Treatment of Advanced Ovarian Cancer — RECRUITING · PHASE2
• RC48 Treatment for Platinum Sensitive Recurrent Ovarian Cancer With HER2 Expression — RECRUITING · PHASE2
• Surgery and Niraparib in Secondary Recurrent Ovarian Cancer (SOC-3 Trial) — RECRUITING · PHASE2
• A Study of Maintenance DCVAC/OvCa After First-line Chemotherapy Added Standard of Care — RECRUITING · PHASE2
• Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma — COMPLETED · PHASE1
• Testing the Combination of the Study Drugs Cediranib and Olaparib in Recurrent Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Determining the Biodistribution of an Imaging Tracer (68Ga-FAPi-46) in Patients With Solid Tumors or Hematologic Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• IMMU-132 in TROP-2 Overexpressed Advanced and Relapsed Ovarian Cancer — NOT_YET_RECRUITING · PHASE1
• National Cancer Institute "Cancer Moonshot Biobank" — ACTIVE_NOT_RECRUITING
• Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study — COMPLETED
• ONC-392 and Pembrolizumab in Platinum Resistant Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Safety, PK and Efficacy of AI-061 in Advanced Solid Tumors — ACTIVE_NOT_RECRUITING · PHASE1
• BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas — ACTIVE_NOT_RECRUITING · PHASE2
• A Study of Azenosertib (ZN-c3) and Niraparib in Subjects With Platinum-Resistant Ovarian Cancer — COMPLETED · PHASE1
• Risk-reducing Strategies, Including Fimbriectomy, in Women With a Germline Mutation Predisposing to Ovarian or Pelvic Cancer — NOT_YET_RECRUITING · NA
• First in Human Study of IMGN151 in Recurrent Gynaecological Cancers — ACTIVE_NOT_RECRUITING · PHASE1
• Diet, Hepcidin, and Chemotherapy RDI — ACTIVE_NOT_RECRUITING
• Prehabilitation Care for Women With Advanced Ovarian Cancer Receiving Neoadjuvant Chemotherapy — ACTIVE_NOT_RECRUITING · NA
• Phase 1b Study of SL-172154 Administered With Combination Agent(s) in Subjects With Ovarian Cancers — COMPLETED · PHASE1
• Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance — NOT_YET_RECRUITING
• Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment — COMPLETED
• A Study of Sovilnesib in Subjects With Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE1
• A Study of STRO-002, an Anti-Folate Receptor Alpha Antibody Drug Conjugate, in Combination With Bevacizumab in Epithelial Ovarian Cancer — TERMINATED · PHASE1
• Phase 2 Study of Pembrolizumab, DPX-Survivac Vaccine and Cyclophosphamide in Advanced Ovarian, Primary Peritoneal or Fallopian Tube Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• Study of STRO-002, an Anti-Folate Receptor Alpha (FolRα) Antibody Drug Conjugate in Ovarian & Endometrial Cancers — COMPLETED · PHASE1
• A Biomarker Screening Protocol for Participants With Solid Tumors — TERMINATED
• A Study to Investigate LYL797 in Adults With Solid Tumors — TERMINATED · PHASE1
• Surgery for Relapsed Ovarian Cancer in Precision — NOT_YET_RECRUITING · PHASE1
• A Study of CDX-585 in Patients With Advanced Malignancies — COMPLETED · PHASE1
• European Trial on Enhanced DNA Repair Inhibition in Ovarian Cancer — COMPLETED · PHASE2
• Phase IB Study to Evaluate the Safety of Selinexor (KPT-330) in Combination With Multiple Standard Chemotherapy or Immunotherapy Agents in Patients With Advanced Malignancies — TERMINATED · PHASE1
• Study of Pembrolizumab Combination With Chemotherapy in Platinum-sensitive Recurrent Low-grade Serous Ovarian Cancer — ACTIVE_NOT_RECRUITING · PHASE2
• NGS-based Germline and Somatic Genetic Test in Ovarian Carcinoma — ACTIVE_NOT_RECRUITING · PHASE4
• MOv19-BBz CAR T Cells in aFR Expressing Recurrent High Grade Serous Ovarian, Fallopian Tube, or Primary Peritoneal Cancer — TERMINATED · PHASE1
• Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY) — ACTIVE_NOT_RECRUITING · PHASE3
• Phase 1 Study of SL-172154 (SIRPα-Fc-CD40L) in Subjects With Ovarian Cancer — COMPLETED · PHASE1

Refine this search